News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Roche (RHHBY) Reports Death in Phase III Hemophilia Study     2/23/2017
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial     2/22/2017
FDA Approval of Siliq for Psoriasis—How Will the Drug Perform in an Already Overcrowded Market?     2/22/2017
This Drug Could Rattle Biogen (BIIB) and Be the Next Billion-Dollar Blockbuster for Celgene (CELG)     2/21/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial     2/20/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/20/2017
SAGE Therapeutics (SAGE) Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity     2/17/2017
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa     2/17/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study     2/16/2017
Bay Area Biotech Ardelyx (ARDX) Rejoices as Lead Drug Hits Phase III Goals     2/16/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients     2/16/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business     2/15/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force     2/15/2017
Oops, They Did it Again: Theranos Failed to Inform Patients of Potentially Botched Diabetes Test     2/14/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal     2/13/2017

News from Around the Web
The Risk Factors For Heart Disease Also Predict Dementia, AHA Reveals     2/23/2017
Cheap Ultrasensitive HIV Sensor To Help Screen Virus In Poorer Places, Instituto de Microelectrónica de Madrid Reveals     2/23/2017
Tiny Fibers Open New Windows Into The Brain, MIT Study Reveals     2/23/2017
Top Pharma Lobbyist Showers Praise on Biogen (BIIB) for Being Anti-Shkreli Like     2/22/2017
This, And Not The Brain, Is What Decides Whether You'll Be Left Or Right Handed, Ruhr-University Reveals     2/22/2017
New App Seeks to Detect Early Dementia, Boston University Reveals     2/21/2017
Could Marijuana Be the Next Miracle Drug For Treating Cancer?     2/20/2017
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug     2/17/2017
How Bristol-Myers Squibb (BMY) And Pfizer (PFE) Are Stomping On Their Blood Thinner Rivals     2/17/2017
Could A Little Bit Of Fasting Bring A Lot Of Health Benefits? University of Southern California Study     2/17/2017
Zika Testing Mistakes Require Re-testing Of Over 400 Specimens     2/17/2017
How Surgical Robots Are Creating Super Surgeons     2/17/2017
Merck & Co. (MRK)'s Alzheimer's Failure Has All Eyes and Hopes Turning to Biogen (BIIB)     2/16/2017
A Bit More Vitamin D May Stop Colds And Flu, Queen Mary University of London Study     2/16/2017
New Star Trek-Like Smart Glasses Give Instant Sight To The Legally Blind     2/16/2017

Press Releases
The World's Richest Doctor's New Cancer Vaccine and NantKwest's Science     2/23/2017
Novartis AG (NVS)'s Cancer Drug Gets a Fast Track Ticket From the FDA     2/23/2017
Cyclacel Pharma (CYCC) Crashes as Leukemia Drug Flunks Key Late-Stage Trial     2/23/2017
The New England Journal of Medicine Publishes Phase Ib Results For Shire (SHPG)'s Investigational Treatment For Hereditary Angioedema, A Rare Genetic Disease     2/23/2017
CBT Pharma Presents Data Demonstrating Anti-Tumor Activity Of Its Programmed Death-1 Antibody, CBT-501, At ASCO-SITC Clinical Oncology Symposium     2/23/2017
Children’s National Health System Experts To Present Data On Novel Approach To Cell Therapy For Cancer Patients     2/23/2017
Amgen (AMGN) Wins European Commission (EC) Approval for Repatha Single-Dose Delivery Option     2/23/2017
Celgene (CELG) Release: FDA Expands Indication For REVLIMID (Lenalidomide) As A Maintenance Treatment For Patients With Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT)     2/23/2017
Novartis AG (NVS) Drug Zykadia Receives FDA Priority Review For First-Line Use In Patients With ALK+ Metastatic NSCLC     2/23/2017
Tocagen Receives Breakthrough Therapy Designation From FDA For Toca 511 & Toca FC In Recurrent High Grade Glioma     2/23/2017
Reata Pharmaceuticals, Inc. Announces Initiation Of Phase II/III Study Of Bardoxolone Methyl In The Treatment Of Chronic Kidney Disease Due To Alport Syndrome     2/23/2017
Madrigal Announces The Initiation Of A Phase II Study Of MGL-3196 In Patients With Heterozygous Familial Hypercholesterolemia (HeFH)     2/23/2017
Resverlogix (RVX.TO) Reports Positive FDA Type B Meeting On Design Issues Relating To A Proposed Phase IIa Kidney Dialysis Trial     2/23/2017
Tocagen Achieves Key Development Milestone For Lead Product: Phase II Randomized Trial In Patients With Recurrent Brain Cancer Fully Enrolled     2/23/2017
MabVax Therapeutics Announces FDA Authorization To Proceed With MVT-1075 In A Phase I Clinical Trial For The Treatment Of Pancreatic Cancer     2/23/2017

//-->